Form D · Other Health Care
INCLINIX INC
Wilmington, NC · CIK 0001423844
Offering snapshot reported Sep 29, 2010 · SEC filing
- Reported sold
- $500K Offering amount: $1M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 24, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 29, 2010 | Initial | $500,000 | No comparison | 2 | SEC filing |
| Jan 11, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-148318
Source: Form D, filed Sep 29, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| J. Tobin Geatz | Director, Executive |
| Marc Klee | Director |
| Joel R. Lanik | Director |
| Richard T. Maclean | Director |
| Jeffery S. Reiniche | Executive |
| Christopher Sleat | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3534 S College Road Suite F
Wilmington, NC, 28412
Wilmington, NC, 28412